SPIRONOLACTONE | A219494 | GRAVITI PHARMACEUTICALS PRIVATE LTD
Highest NADAC/Unit
$0.1759
per ea
Lowest NADAC/Unit
$0.0443
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 64980070801SPIRONOLACTONE 100 MG TABLET | $0.1759 | EA | Generic | — | 2026-06-17 |
| 64980070850SPIRONOLACTONE 100 MG TABLET | $0.1759 | EA | Generic | — | 2026-06-17 |
| 64980070701SPIRONOLACTONE 50 MG TABLET | $0.0875 | EA | Generic | — | 2026-06-17 |
| 64980070750SPIRONOLACTONE 50 MG TABLET | $0.0875 | EA | Generic | — | 2026-06-17 |
| 64980070601SPIRONOLACTONE 25 MG TABLET | $0.0443 | EA | Generic | — | 2026-06-17 |
| 64980070650SPIRONOLACTONE 25 MG TABLET | $0.0443 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.